TrimRx's Blog

Mounjaro produces 3-5% body weight loss in month one through dual GIP/GLP-1 action — slower than expected but clinically significant with proper titration.

Mounjaro can trigger or worsen body dysmorphia through rapid weight loss and shifting self-perception. Understand the psychological risks and warning

Mounjaro doesn’t cause eating disorders but can worsen existing patterns. Learn how GLP-1 therapy interacts with disordered eating and when it’s

Most Mounjaro patients lose 12–15% of body weight in 3 months — here’s the science behind it, realistic timelines, and what happens at each dose level.

Mounjaro delivers 15-22% body weight reduction in six months when combined with dietary adjustments and weekly injections at therapeutic doses.

Mounjaro 2 year results show sustained weight loss averaging 15-21% body weight at 104 weeks, with metabolic benefits persisting across long-term use.

Mounjaro long-term studies show sustained 15–21% weight loss at 72+ weeks, but 5-year data remains limited. Evidence, expectations, and realistic outcomes.

Mounjaro 1 year results show 15–22.5% body weight loss in clinical trials. Most patients maintain results with consistent dosing and lifestyle habits.

Tirzepatide doesn’t directly impair strength, but rapid weight loss and reduced calorie intake can affect powerlifting performance if not managed